tiprankstipranks
Aptevo Therapeutics Inc (APVO)
NASDAQ:APVO
US Market
APVO
Aptevo Therapeutics
RESEARCH TOOLSreports
Want to see APVO full AI Analyst Report?

Aptevo Therapeutics (APVO) Income Statement

742 Followers

Aptevo Therapeutics Income Statement

Last quarter (Q4 2025), Aptevo Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Aptevo Therapeutics's net income was $-5.81M. See Aptevo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 3.11M$ 12.29M
Gross Profit
$ -240.00K$ -352.00K$ 0.00$ 3.11M$ 12.29M
Operating Expenses
$ 26.07M$ 24.25M$ 28.88M$ 31.75M$ 33.69M
Depreciation and Amortization
$ 240.00K$ 352.00K$ 567.00K$ 901.00K$ 1.14M
EBITDA
$ -26.07M$ -23.78M$ -28.31M$ -27.74M$ -20.26M
Operating Income
$ -26.31M$ -24.60M$ -28.88M$ -28.64M$ -21.40M
Other Income/Expenses
$ 345.00K$ 472.00K$ 10.23M$ 35.66M$ -8.01M
Pretax Income
$ -25.97M$ -24.13M$ -18.65M$ 7.01M$ -29.41M
Net Income
$ -25.97M$ -24.13M$ -17.41M$ 8.03M$ -28.46M
Per Share Metrics
Basic EPS
$ -87.27$ -31.46K$ -834.04K$ 922.39K$ -3.56M
Diluted EPS
$ -87.27$ -31.46K$ -834.04K$ 921.91K$ -3.56M
Weighted Average Shares Outstanding
 3.15K----
Weighted Average Shares Outstanding (Diluted)
 3.15K----
Currency in USD

Aptevo Therapeutics Earnings and Revenue History